
We’re renewing our website! (WIP right NOW!)
Our new homepage is on its way. In the meantime, here’s a short introduction.
About Incircular
Incircular B.V. is a biotech spin-off from Vrije Universiteit Amsterdam. Our proprietary INCYPRO platform uses structure-guided chemical crosslinking to stabilise therapeutic proteins. It reinforces a protein’s natural fold with minimal modification, which addresses instability, aggregation and short half-life. Our lead program is a next-generation, stabilised asparaginase for children with acute lymphoblastic leukaemia (ALL). Further programs focus on the stabilisation of other therapeutically relevant proteins & protein complexes.
Get in touch
We’re happy to talk with partners, investors and researchers.
Email: info@incircular.com

